Immunotherapy Strategies Against Multiple Myeloma.

about

Immunotherapy Strategies Against Multiple Myeloma.

Item

http://www.wikidata.org/entity/Q49995864

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Immunotherapy Strategies Against Multiple Myeloma.

@en

Immunotherapy Strategies Against Multiple Myeloma.

@nl

type

Item

label

Immunotherapy Strategies Against Multiple Myeloma.

@en

Immunotherapy Strategies Against Multiple Myeloma.

@nl

prefLabel

Immunotherapy Strategies Against Multiple Myeloma.

@en

Immunotherapy Strategies Against Multiple Myeloma.

@nl

P1476

Immunotherapy Strategies Against Multiple Myeloma.

@en

P2093

Han Li

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

Lin Chen

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Qiang Liu

http://www.w3.org/2001/XMLSchema#string

Shuang Gao

http://www.w3.org/2001/XMLSchema#string

Su Liu

http://www.w3.org/2001/XMLSchema#string

Tinghui Yan

http://www.w3.org/2001/XMLSchema#string

Yafei Wang

http://www.w3.org/2001/XMLSchema#string

Zeng Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of lenalidomide in hematological malignancies

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives

Radioimmunotherapy of human tumours

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

P304

717-726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1533034617743155

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

immunotherapy

P932

5762093

http://www.w3.org/2001/XMLSchema#string